Discover

AUPH
Aurinia Pharmaceuticals Inc.
15.46
1 x 15.46
15 x 15.47
bid
ask
+
0.02
0.10%
12:35 PM
timesize
Ytd-3.04%
1y35.30%
15.31
day range
15.59
10.34
52 week range
19.25
Open15.49Prev Close15.45Low15.31High15.59Mkt Cap1.99B
Vol286.63KAvg Vol1.48MEPS1.02P/E15.16Forward P/E14.86
Beta1.42Short Ratio4.70Inst. Own59.00%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning07-3050-d Avg15.92200-d Avg15.271yr Est17.00

AUPH News

benzinga.com
RBC Capital Maintains Sector Perform on Aurinia Pharmaceuticals, Raises Price Target to $16

RBC Capital analyst Douglas Miehm maintains Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Sector P

Aurinia Pharmaceuticals (AUPH) Surpasses Q2 Earnings Estimates
zacks.com
Aurinia Pharmaceuticals (AUPH) Surpasses Q2 Earnings Estimates

Aurinia Pharmaceuticals (AUPH) came out with quarterly earnings of $0.28 per share, beating the Zack

benzinga.com
Aurinia Pharmaceuticals Affirms FY2026 Sales Guidance of $315.000M-$325.000M vs $323.065M Est

Aurinia Pharmaceuticals (NASDAQ:AUPH) affirms FY2026 sales outlook from $315.000 million-$325.000 mi

benzinga.com
Aurinia Pharmaceuticals Q2 EPS $0.28 Beats $0.24 Estimate, Sales $83.220M Beat $79.357M Estimate

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly earnings of $0.28 per share which beat the

Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Provides Update on Recent Business Progress
businesswire.com
Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 a

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Reports Financial Resul

Playing The Biotech Breakout With Insiders
seekingalpha.com
Playing The Biotech Breakout With Insiders

Biotech stocks are consolidating after a breakout, with bullish insider Wall Street sentiment. AbCel

Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis
gurufocus.com
Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Beli

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced the initiation of PRESERVE, a Phase 4, m

Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis
businesswire.com
Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Beli

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) tod

Aurinia (AUPH) Upgraded to Strong Buy: Here's Why
zacks.com
Aurinia (AUPH) Upgraded to Strong Buy: Here's Why

Aurinia (AUPH) might move higher on growing optimism about its earnings prospects, which is reflecte

Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
zacks.com
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker

Indivior, Aurinia, Ironwood, Altimmune and Marker have been highlighted in this Industry Outlook art

5 Small Drug Stocks to Invest in Amid a Biotech Comeback
zacks.com
5 Small Drug Stocks to Invest in Amid a Biotech Comeback

Innovation is at its peak in the Zacks Medical-Drugs industry. INDV, AUPH, IRWD, ALT and MRKR may pr

Aurinia (AUPH) Moves 6.5% Higher: Will This Strength Last?
zacks.com
Aurinia (AUPH) Moves 6.5% Higher: Will This Strength Last?

Aurinia (AUPH) saw its shares surge in the last session with trading volume being higher than averag

Aurinia Pharmaceuticals' (AUPH) CEO Bought 815,000 Shares for $12.5 Million
fool.com
Aurinia Pharmaceuticals' (AUPH) CEO Bought 815,000 Shares for $12.5 Million

814,606 common shares acquired for a total transaction value of approximately $12.5 million, based o

10 Health Care Stocks Whale Activity In Today's Session
benzinga.com
10 Health Care Stocks Whale Activity In Today's Session

Aurinia: Cash-Generating Today, Pipeline-Driven Tomorrow
seekingalpha.com
Aurinia: Cash-Generating Today, Pipeline-Driven Tomorrow

Aurinia Pharmaceuticals (AUPH) is positioned for profitable growth, driven by Lupkynis and pipeline

benzinga.com
Aurinia Pharmaceuticals' New Analysis Of Aurora 1 Phase 3 Study Of Lupkynis For Lupus Nephritis Show

Hazard ratios (HRs) favored treatment with LUPKYNIS for the following individual components of the c

LUPKYNIS Associated with a Statistically Significant 53% Reduction in Risk of Renal-Related Event or Death
businesswire.com
LUPKYNIS Associated with a Statistically Significant 53% Reduction in Risk of Renal-Related Event or

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--LUPKYNIS Associated with a Statistically Signif

Aurinia Pharmaceuticals Inc. (AUPH) Shareholder/Analyst Call Prepared Remarks Transcript
seekingalpha.com
Aurinia Pharmaceuticals Inc. (AUPH) Shareholder/Analyst Call Prepared Remarks Transcript

Aurinia Pharmaceuticals Inc. (AUPH) Shareholder/Analyst Call Prepared Remarks Transcript

benzinga.com
Tang Capital Raises Aurinia Pharmaceuticals Holding to 10%

Tang Capital Management, LLC announces that on June 2, 2026, it acquired 206,005 common shares (the

Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences
feeds.newsfilecorp.com
Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences

Little Falls, New Jersey--(Newsfile Corp. - May 19, 2026) - Alliance Advisors is pleased to congratu

Parabolic AI rally has bulls eyeing a comeback for this one-time meme metal trade
cnbc.com
Parabolic AI rally has bulls eyeing a comeback for this one-time meme metal trade

Silver prices surged 7% Monday to the highest since March.

Aurinia Pharmaceuticals (AUPH) Q1 Earnings and Revenues Top Estimates
zacks.com
Aurinia Pharmaceuticals (AUPH) Q1 Earnings and Revenues Top Estimates

Aurinia Pharmaceuticals (AUPH) came out with quarterly earnings of $0.25 per share, beating the Zack

benzinga.com
Aurinia Pharmaceuticals Affirms FY2026 Sales Guidance of $315.000M-$325.000M vs $326.190M Est

Aurinia Pharmaceuticals (NASDAQ:AUPH) affirms FY2026 sales outlook from $315.000 million-$325.000 mi

benzinga.com
Aurinia Pharmaceuticals Q1 EPS $0.25 Beats $0.19 Estimate, Sales $77.705M Beat $77.390M Estimate

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly earnings of $0.25 per share which beat the

Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026 and Provides Update on Recent Business Progress
businesswire.com
Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026 and Prov

ROCKVILLE, Maryland & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Reports Financial

Aurinia Pharmaceuticals (NASDAQ:AUPH) vs. Cronos Group (NASDAQ:CRON) Financial Comparison
defenseworld.net
Aurinia Pharmaceuticals (NASDAQ:AUPH) vs. Cronos Group (NASDAQ:CRON) Financial Comparison

Aurinia Pharmaceuticals (NASDAQ: AUPH - Get Free Report) and Cronos Group (NASDAQ: CRON - Get Free R

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Given Consensus Recommendation of “Hold” by Analysts
defenseworld.net
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Given Consensus Recommendation of “Hold” by Analysts

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH - Get Free Report) (TSE: AUP) has earned an average recomm

SG Americas Securities LLC Grows Position in Aurinia Pharmaceuticals Inc $AUPH
defenseworld.net
SG Americas Securities LLC Grows Position in Aurinia Pharmaceuticals Inc $AUPH

SG Americas Securities LLC raised its holdings in Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) (TSE: A

benzinga.com
Aurinia Pharmaceuticals Signs Agreement To Acquire Kezar Life Sciences For $6.955/Share In Cash

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a biopharmaceutical company focused on delivering thera

Why Aurinia Pharmaceuticals Stock Is Surging Monday Morning
benzinga.com
Why Aurinia Pharmaceuticals Stock Is Surging Monday Morning

Aurinia Pharmaceuticals shares are trading higher Monday after announcing a leadership transition se

Aurinia Pharmaceuticals (AUPH) Stock Drops After Strong Quarter, Softer Forward Revenue Targets
benzinga.com
Aurinia Pharmaceuticals (AUPH) Stock Drops After Strong Quarter, Softer Forward Revenue Targets

Aurinia Pharmaceuticals shares are trading lower Thursday afternoon after the lupus-focused drugmake

Earnings Breakdown: Aurinia Pharmaceuticals Q4
benzinga.com
Earnings Breakdown: Aurinia Pharmaceuticals Q4

Earnings Scheduled For February 26, 2026
benzinga.com
Earnings Scheduled For February 26, 2026

Earnings Summary: Aurinia Pharmaceuticals Q4
benzinga.com
Earnings Summary: Aurinia Pharmaceuticals Q4

benzinga.com
Aurinia Pharmaceuticals Sees FY2026 Sales $315.000M-$325.000M vs $326.858M Est

Aurinia Pharmaceuticals (NASDAQ:AUPH) sees FY2026 sales of $315.000 million-$325.000 million vs $326

benzinga.com
Aurinia Pharmaceuticals Q4 EPS $1.53, Sales $77.114M Beat $74.845M Estimate

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly earnings of $1.53 per share which beat the

Earnings Preview: Aurinia Pharmaceuticals
benzinga.com
Earnings Preview: Aurinia Pharmaceuticals

benzinga.com
Leerink Partners Downgrades Aurinia Pharmaceuticals to Market Perform, Raises Price Target to $16

Leerink Partners analyst Joseph Schwartz downgrades Aurinia Pharmaceuticals (NASDAQ:AUPH) from Ou

Earnings Scheduled For November 4, 2025
benzinga.com
Earnings Scheduled For November 4, 2025

benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Gainers SciSparc (NASDAQ: SPRC) shares increased by 28.2% to $5.68 during Monday's after-market

benzinga.com
Earnings Scheduled For July 31, 2025

benzinga.com
Earnings Scheduled For May 12, 2025

benzinga.com
Earnings Scheduled For February 27, 2025

benzinga.com
Earnings Scheduled For February 15, 2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earning

benzinga.com
Earnings Scheduled For November 2, 2023

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear

benzinga.com
Earnings Scheduled For August 3, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

benzinga.com
Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Sess

Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launc

benzinga.com
Earnings Scheduled For May 4, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a

benzinga.com
Earnings Scheduled For February 28, 2023

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  During Friday's trading, 293 companies set new 52-week lows.